Coeptis Therapeutics Holdings Inc (COEP)

Finanzdaten der Coeptis Therapeutics Holdings Inc-Aktie (COEP)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expenses	17.47% 2.9224	3.5409	7.8314	3.638	6.4494
Interest Income/Expense	1,350% 0.2005	0.0138	0.0198	0.0426	0.0314
Depreciation and Amortization	0.25	-	-	-	-
Operating Income/Loss	17.47% -2.9224	-3.5409	-7.8314	-3.638	-6.4494
Nonoperating Income/Loss	83.66% -0.079	-0.4835	1.5705	0.525	-1.4189
Income/Loss From Continuing Operations Before Tax	25.42% -3.0014	-4.0244	-6.2609	-3.113	-7.8682
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	25.42% -3.0014	-4.0244	-6.2609	-3.113	-7.8682
Net Income/Loss	25.42% -3.0014	-4.0244	-6.2609	-3.113	-7.8682
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,201% 35.54	2.7326	26.65	21.81	20.08
Diluted Average Shares	1,201% 35.54	2.7326	26.65	21.81	20.08
Basic Earnings Per Share	0.00% -0.08	-0.08	-0.23	-0.14	-0.39
Diluted Earnings Per Share	0.00% -0.08	-0.08	-0.23	-0.14	-0.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-